Head to Head Analysis: BIO-key International (NASDAQ:BKYI) & Procore Technologies (NYSE:PCOR)

BIO-key International (NASDAQ:BKYI) and Procore Technologies (NYSE:PCOR) are both technology companies, but which is the better investment? We will compare the two companies based on the strength of their earnings, valuation, dividends, risk, profitability, analyst recommendations and institutional ownership.

Institutional and Insider Ownership

26.5% of BIO-key International shares are held by institutional investors. Comparatively, 81.1% of Procore Technologies shares are held by institutional investors. 4.0% of BIO-key International shares are held by insiders. Comparatively, 16.8% of Procore Technologies shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

Analyst Ratings

This is a summary of recent recommendations and price targets for BIO-key International and Procore Technologies, as provided by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
BIO-key International	1	1	0	0	1.50
Procore Technologies	1	2	18	0	2.81

Procore Technologies has a consensus price target of $80.35, indicating a potential upside of 3.59%. Given Procore Technologies’ stronger consensus rating and higher possible upside, analysts clearly believe Procore Technologies is more favorable than BIO-key International.

Volatility & Risk

BIO-key International has a beta of 0.52, indicating that its stock price is 48% less volatile than the S&P 500. Comparatively, Procore Technologies has a beta of 0.75, indicating that its stock price is 25% less volatile than the S&P 500.

Profitability

This table compares BIO-key International and Procore Technologies’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
BIO-key International	-50.01%	-67.31%	-40.28%
Procore Technologies	-2.31%	2.67%	1.34%

Earnings and Valuation

This table compares BIO-key International and Procore Technologies”s gross revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
BIO-key International	$6.09 million	0.71	-$7.16 million	($4.11)	-0.52
Procore Technologies	$1.32 billion	8.77	-$100.78 million	($0.23)	-337.25

BIO-key International has higher earnings, but lower revenue than Procore Technologies. Procore Technologies is trading at a lower price-to-earnings ratio than BIO-key International, indicating that it is currently the more affordable of the two stocks.

Summary

Procore Technologies beats BIO-key International on 12 of the 14 factors compared between the two stocks.

About BIO-key International

BIO-key International, Inc. (NASDAQ: BKYI) develops biometric authentication and identity and access management solutions. The company helps organizations secure access to applications, networks, devices and data through fingerprint recognition and other authentication methods designed to reduce reliance on passwords. Its product portfolio includes PortalGuard, an identity and access management platform that supports single sign-on, multifactor authentication, self-service password management and access control.

About Procore Technologies

Procore Technologies provides cloud-based construction management software designed to help construction companies plan, manage and execute projects. Its platform connects project teams and stakeholders, including owners, general contractors, specialty contractors and design professionals. Procore’s products support project management, construction financials, workforce coordination, quality and safety processes, and project data and analytics. The platform also offers integrations with third-party applications to help customers connect construction workflows and business systems.